Reccurence of Heterotopic Ossification as the Result of Total Hip Endoprosthesis Dislocation: A Case Report
- Authors: Efimov G.A.1, Cherkasov M.A.1, Goncharov M.Y.1, Efimov N.N.1
-
Affiliations:
- Vreden National Medical Research Center of Traumatology and Orthopedics
- Issue: Vol 28, No 2 (2022)
- Pages: 97-104
- Section: Case Reports
- URL: https://ogarev-online.ru/2311-2905/article/view/124888
- DOI: https://doi.org/10.17816/2311-2905-1691
- ID: 124888
Cite item
Abstract
Background. Heterotopic ossification (HO) is the formation of mature bone in soft tissues. HO in the hip area can be a consequence of both injury to the nervous system and local trauma. After total hip arthroplasty HO develops in 30% of cases.
The aim of the study is to demonstrate a rare clinical case of a recurrence of HO in patient after a primary total hip arthroplasty, accompanied by ankylosing.
Case presentation. A 32-year-old patient was admitted to the clinic for revision hip arthroplasty with a diagnosis «long-standing dislocation of the right hip joint endoprosthesis head, heterotopic ossification» 3 years after dislocation. During the surgery, there were difficulties with the sciatic nerve dissection, as well as the structures of the endoprosthesis. We removed all the ossifications that obstructed the dislocation of the endoprosthesis. The patient had sciatic nerve neuropathy on the right lower limb with lesions of the fibular and tibial nerves on the background of edema. The patient was discharged on the 21st day. The presented clinical case is interesting because the patient’s relapse could be caused by a combination of various risk factors. Taking into account the fact that the injury was received as a result of an accident and the patient had a fracture of the bones of the contralateral shin, it could be the effect of a local hip injury that aggravated the process.
Conclusions. This clinical observation highlights the importance of preventing possible complications after surgery and maintaining feedback with patients, especially those belonging to the high-risk group. It is likely that with adequate prevention of the HO formation and timely reduction of dislocation, the problems described in the article after primary total hip arthroplasty could have been avoided.
Full Text
##article.viewOnOriginalSite##About the authors
Gleb A. Efimov
Vreden National Medical Research Center of Traumatology and Orthopedics
Author for correspondence.
Email: glebefimovv@gmail.com
ORCID iD: 0000-0003-3310-0799
SPIN-code: 1689-2611
clinical resident
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Magomed A. Cherkasov
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: medik@gmail.com
ORCID iD: 0000-0003-2799-532X
Cand. Sci. (Med.)
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Maksim Yu. Goncharov
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: goncharov71@list.ru
ORCID iD: 0000-0001-6435-7939
Cand. Sci. (Med.)
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427Nicolay N. Efimov
Vreden National Medical Research Center of Traumatology and Orthopedics
Email: efimov-n-n@mail.ru
ORCID iD: 0000-0002-1813-3421
Cand. Sci. (Med.)
Russian Federation, 8, Akademika Baykova str., St. Petersburg, 195427References
- Ranganathan K., Loder S., Agarwal S., Wong V.С., Forsberg J., Davis T.A. et al. Heterotopic Ossification: Basic-Science Principles and Clinical Correlates. J Bone Joint Surg Am. 2015;97(13):1101-1111. doi: 10.2106/JBJS.N.01056.
- Yolcu Y.U., Wahood W., Goyal A., Alvi M.A., Reeves R.K., Qu W. et al. Factors Associated with Higher Rates of Heterotopic Ossification after Spinal Cord Injury: A Systematic Review and Meta-Analysis. Clin Neurol Neurosurg. 2020;195:105821. doi: 10.1016/j.clineuro.2020.105821.
- Zhu Y., Zhang F., Chen W., Zhang Q., Liu S., Zhang Y. Incidence and risk factors for heterotopic ossification after total hip arthroplasty: a meta-analysis. Arch Orthop Trauma Surg. 2015;135(9):1307-1314. doi: 10.1007/s00402-015-2277-8.
- Kan S.L., Yang B., Ning G.Z., Chen L.X., Li Y.L., Gao S.J., Chen X.C. et al. Nonsteroidal anti-inflammatory drugs as prophylaxis for heterotopic ossification after total hip arthroplasty. Medicine (Baltimore). 2015;94(18):e828. doi: 10.1097/MD.0000000000000828.
- Kjaersgaard-Andersen P.K., Nafei A., Teichert G., Kristensen O., Schmidt S.A., Keller J. et al. Indomethacin for prevention of heterotopic ossification. A randomized controlled study in 41 hip arthroplasties. Acta Orthop Scand. 1993;64(6):639-642. doi: 10.3109/17453679308994587.
- Mier P.D., van den Hurk J.J. Lysosomal hydrolases of the epidermis. I. Glycosidases. Br J Dermatol. 1975;93(1): 1-10. doi: 10.1111/j.1365-2133.1975.tb06468.x.
- Brooker A.F., Bowerman J.W., Robinson R.A., Riley L.H. Jr. Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am. 1973;55(8):1629-1632.
- Shehab D., Elgazzar A.H., Collier D.B. Heterotopic ossification. J Nucl Med. 2002;43(3):346-353.
- Sullivan M.P., Torres S.J., Mehta S., Ahn J. Heterotopic ossification after central nervous system trauma: a current review. Bone Joint Res. 2013;2(3):51-57. doi: 10.1302/2046-3758.23.2000152.
- Łęgosz P., Otworowski M., Sibilska A., Starszak K., Kotrych D., Kwapisz A. et al. Heterotopic Ossification: A Challenging Complication of Total Hip Arthroplasty: Risk Factors, Diagnosis, Prophylaxis, and Treatment. Biomed Res Int. 2019;2019:3860142. doi: 10.1155/2019/3860142.
- Popovic M., Agarwal A., Zhang L., Yip C., Kreder H.J., Nousiainen M.T. et al. Radiotherapy for the prophylaxis of heterotopic ossification: a systematic review and meta-analysis of published data. Radiother Oncol. 2014;113:10-17. doi: 10.1016/j.radonc.2014.08.025.
- Cholok D., Chung M.T., Ranganathan K., Ucer S., Day D., Davis T.A. et al. Heterotopic ossification and the elucidation of pathologic differentiation. Bone. 2018;109:12-21. doi: 10.1016/j.bone.2017.09.019.
- Svircev J.N., Wallbom A.S. False-negative triple-phase bone scans in spinal cord injury to detect clinically suspect heterotopic ossification: a case series. J Spinal Cord Med. 2008;31:194-196. doi: 10.1080/10790268.2008.11760711.
- Егиазарян К.А., Коробушкин Г.В., Сиротин И.В., Абилемец А.С., Юусибов Р.Р., Субботин Н.А. Клинический случай оперативного лечения приобретенной гетеротопической оссификации у пациента с тяжелой сочетанной травмой. Политравма. 2018;(2):75-81. Egiazaryan K.A., Korobushkin G.V., Sirotin I.V., Abilemets A.S., Yuusibov R.R., Subbotin N.A. [A clinical case of surgical treatment of acquired heterotopic ossification in a patient with polytrauma]. Polytravma [Polytrauma]. 2018; (2): 75-81. (In Russian).
- Молодов М.А., Даниляк В.В., Ключевский В.В., Гильфанов С.И., Ключевский В.В., Вергай А.А. Факторы риска вывихов тотальных эндопротезов тазобедренного сустава. Травматология и ортопедия России. 2013;(2):23-30. doi: 10.21823/2311-2905-2013-0-2-65-71. Molodov M.A., Danilyak V.V., Kluchevsky V.V., Gilfanov S.I., Kluchevsky V.V., Vergay A.A. [Risk factors for total hip arthroplasty dislocations]. Travmatologiya i ortopediya Rossii [Traumatology and Orthopedics of Russia]. 2013;19(2):23-30. (In Russian). doi: 10.21823/2311-2905-2013-0-2-65-71.
- Vanden Bossche L.C., Van Maele G., Wojtowicz I., Bru I., Decorte T., De Muynck M. et al. Free radical scavengers versus methylprednisolone in the prevention of experimentally induced heterotopic ossification. J Orthop Res. 2009;27(6):748-751. doi: 10.1002/jor.20817.
- Romanò C.L., Duci D., Romanò D., Mazza M., Meani E. Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty. 2004;19(1):14-18. doi: 10.1016/s0883-5403(03)00279-1.
- Jo S., J.H. Jimenez Almonte J.H., Sierra R.J. The Cumulative Risk of Re-dislocation After Revision THA Performed for Instability Increases Close to 35% at 15 years. J Arthroplasty. 2015;30(7):1177-1182. doi: 10.1016/j.arth.2015.02.001.
- Chalmers B.P., Ledford C.K., Taunton M.J., Sierra R.J., Lewallen D.G., Trousdale R.T. Cementation of a Dual Mobility Construct in Recurrently Dislocating and High Risk Patients Undergoing Revision Total Arthroplasty. J Arthroplasty. 2018;33(5):1501-1506. doi: 10.1016/j.arth.2017.11.055.
- Загородний Н.В., Бухтин К.М., Чрагян Г.А., Каграманов С.В., Галаев Х.И. Метод ревизии вертлужного компонента эндопротеза тазобедренного сустава без удаления ранее установленной чашки. Вестник травматологии и ортопедии им. Н.Н. Приорова. 2014;(4):73-74. doi: 10.17816/vto20140473-74. Zagorodniy N.V., Bukhtin K.M., Chragyan G.A., Kagramanov S.V., Galaev Kh.I. [Revision of hip endoprosthesis acetabular component without removal of reviously implanted cup]. Vestnik travmatologii i ortopedii im. N.N. Priorova [N.N. Priorov Journal of Traumatology and Orthopedics]. 2014;(4):73-74. (In Russian). doi: 10.17816/vto20140473-74.
Supplementary files
